Mechanistic description
FRAP-based measurement of TDP-43 liquid-liquid phase separation state provides a continuous biomarker of nuclear-cytoplasmic compartmentalization. Endogenous TDP-43-eGFP knock-in in iPSC neurons enables longitudinal monitoring; orthogonal validation via mAb414 nuclear pore integrity anchors imaging to ultrastructure. Primary constraint is imaging endpoint gap—two-photon FRAP is not deployable in standard trials; PET ligand development is the critical path to clinical utility.
Mechanism / pathway
- TARDBP (TDP-43 protein); IPO4/IP09 (nuclear import receptors as secondary targets)
- neuroscience
Evidence for (8)
TDP-43 pathology present in >95% of ALS cases
Nuclear import defects cause cytoplasmic TDP-43 accumulation
Phase separation of TDP-43 directly observed by super-resolution microscopy
TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43.
Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion.
TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells.
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
TDP-43 nuclear condensation and neurodegenerative proteinopathies.
Evidence against (2)
FRAP measures protein mobility influenced by viscosity and crowding, not exclusively liquid-to-solid transition; cannot distinguish phase separation defects from nuclear import defects without orthogonal anchor
TDP-43 aggregates may form via mechanisms distinct from liquid-to-solid phase transition, making FRAP kinetics an indirect read-out
Evidence matrix
Supporting
- TDP-43 pathology present in >95% of ALS cases PMID:19042910
- Nuclear import defects cause cytoplasmic TDP-43 accumulation PMID:30540933
- Phase separation of TDP-43 directly observed by super-resolution microscopy PMID:31439799
- TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43. PMID:40157356 · 2025 · Neuron
- Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion. PMID:38941189 · 2024 · Cell Rep
- TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells. PMID:39116527 · 2024 · Redox Biol
- TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. PMID:29311743 · 2018 · Nat Neurosci
- TDP-43 nuclear condensation and neurodegenerative proteinopathies. PMID:39327159 · 2024 · Trends Neurosci
Contradicting
- FRAP measures protein mobility influenced by viscosity and crowding, not exclusively liquid-to-solid transition; cannot distinguish phase separation defects from nuclear import defects without orthogonal anchor
- TDP-43 aggregates may form via mechanisms distinct from liquid-to-solid phase transition, making FRAP kinetics an indirect read-out
Bayesian persona consensus
scidex.consensus.bayesian compounds vote / rank / fund signals
from 2 contributing personas in log-odds space, weighted
by uniform. Prior 50%.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). TDP-43 condensation thermodynamics as a therapeutic target and biomarker for nu…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-6f6c9d3c
@misc{scidex_hypothesis_h6f6c9d3,
title = {TDP-43 condensation thermodynamics as a therapeutic target and biomarker for nu…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-6f6c9d3c},
note = {SciDEX artifact hypothesis:h-6f6c9d3c}
}